Disease Markers
Volume 2017 (2017), Article ID 9617615, 1 page
https://doi.org/10.1155/2017/9617615

Corrigendum

Corrigendum to “Expression and Clinical Significance of Cancer Stem Cell Markers CD24, CD44, and CD133 in Pancreatic Ductal Adenocarcinoma and Chronic Pancreatitis”

L. Durko,¹ W. Wlodarski,¹ O. Stasikowska-Kanicka,² M. Wagrowska-Danilewicz,² M. Danilewicz,³ P. Hogendorf,⁴ J. Strzelczyk,⁴ and E. Malecka-Panas¹

¹Department of Digestive Tract Diseases, Medical University of Lodz, Lodz, Poland
²Department of Nephropathology, Medical University of Lodz, Lodz, Poland
³Department of Pathomorphology, Medical University of Lodz, Lodz, Poland
⁴Department of General and Transplant Surgery, Medical University of Lodz, Lodz, Poland

Correspondence should be addressed to L. Durko; lukasz.durko@umed.lodz.pl

Received 12 July 2017; Accepted 26 July 2017; Published 20 August 2017

Copyright © 2017 L. Durko et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

In the article titled “Expression and Clinical Significance of Cancer Stem Cell Markers CD24, CD44, and CD133 in Pancreatic Ductal Adenocarcinoma and Chronic Pancreatitis” [1], the affiliation listed for Dr. O. Stasikowska-Kanicka and Dr. M. Wagrowska-Danilewicz was incorrect. The corrected authors’ list and affiliations are shown above.

References

L. Durko, W. Wlodarski, O. Stasikowska-Kanicka et al., “Expression and clinical significance of cancer stem cell markers CD24, CD44, and CD133 in pancreatic ductal adenocarcinoma and chronic pancreatitis,” Disease Markers, vol. 2017, Article ID 3276806, 7 pages, 2017.